{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "exchange": "ASX", "shortName": "NOVA EYE FPO", "longName": "Nova Eye Medical Limited", "messageBoardId": "finmb_1898661", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "esgPopulated": false, "regularMarketChangePercent": -4.000002, "regularMarketPrice": 0.24, "marketState": "POSTPOST", "fiftyTwoWeekHighChangePercent": -0.32394364, "fiftyTwoWeekLow": 0.18, "fiftyTwoWeekHigh": 0.355, "earningsTimestamp": 1677618171, "earningsTimestampStart": 1677618171, "earningsTimestampEnd": 1677618171, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.08, "epsForward": -0.03, "epsCurrentYear": -0.04, "priceEpsCurrentYear": -6.0, "sharesOutstanding": 190328000, "bookValue": 0.17, "fiftyDayAverage": 0.2477, "fiftyDayAverageChange": -0.007700011, "fiftyDayAverageChangePercent": -0.031086035, "twoHundredDayAverage": 0.2553875, "twoHundredDayAverageChange": -0.01538752, "twoHundredDayAverageChangePercent": -0.060251653, "marketCap": 45678720, "forwardPE": -8.0, "priceToBook": 1.4117646, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": -0.010000005, "regularMarketTime": 1683871827, "regularMarketDayHigh": 0.25, "regularMarketDayRange": "0.235 - 0.25", "regularMarketDayLow": 0.235, "regularMarketVolume": 582293, "regularMarketPreviousClose": 0.25, "bid": 0.235, "ask": 0.24, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.25, "averageDailyVolume3Month": 397487, "averageDailyVolume10Day": 584028, "fiftyTwoWeekLowChange": 0.059999987, "fiftyTwoWeekLowChangePercent": 0.33333325, "fiftyTwoWeekRange": "0.18 - 0.355", "fiftyTwoWeekHighChange": -0.114999995, "firstTradeDateMilliseconds": 932947200000, "symbol": "EYE.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "107 Rundle Street", "city": "Kent Town", "state": "SA", "zip": "5067", "country": "Australia", "phone": "61 8 8362 0193", "fax": "61 8 8362 0193", "website": "https://nova-eye.com", "industry": "Medical Devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Victor  Previn B.E., B.Eng", "age": 64, "title": "Founder & Exec. Chairman", "yearBorn": 1958, "fiscalYear": 2022, "totalPay": {"raw": 220141, "fmt": "220.14k", "longFmt": "220,141"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D.", "age": 60, "title": "MD & Exec. Director", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 219578, "fmt": "219.58k", "longFmt": "219,578"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Liam  Cook", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Keith  Byrne", "title": "VP of Global Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mark  Flynn", "title": "Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kate  Hunt", "title": "Head of Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David  Lubeck M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Joaquin V. Wolff", "age": 64, "title": "Pres of Ellex iTrack", "yearBorn": 1958, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kimberley  Menzies", "title": "Group Financial Controller & Global Fin. Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Simon Jeremy Newton Gray BEc, C.A., CA", "age": 63, "title": "Company Sec.", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}